- Home
- ACIU vs ONEW Comparison
ACIU vs ONEW Comparison
Compare ACIU & ONEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- ONEW
- Stock Information
- Founded
- ACIU 2003
- ONEW 2014
- Country
- ACIU Switzerland
- ONEW United States
- Employees
- ACIU N/A
- ONEW N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- ONEW Auto & Home Supply Stores
- Sector
- ACIU Health Care
- ONEW Consumer Discretionary
- Exchange
- ACIU Nasdaq
- ONEW Nasdaq
- Market Cap
- ACIU 213.3M
- ONEW 284.0M
- IPO Year
- ACIU 2016
- ONEW 2020
- Fundamental
- Price
- ACIU $2.46
- ONEW $15.48
- Analyst Decision
- ACIU Strong Buy
- ONEW Buy
- Analyst Count
- ACIU 2
- ONEW 8
- Target Price
- ACIU $10.00
- ONEW $19.43
- AVG Volume (30 Days)
- ACIU 136.3K
- ONEW 94.0K
- Earning Date
- ACIU 11-04-2025
- ONEW 11-13-2025
- Dividend Yield
- ACIU N/A
- ONEW N/A
- EPS Growth
- ACIU N/A
- ONEW N/A
- EPS
- ACIU N/A
- ONEW N/A
- Revenue
- ACIU $36,362,036.00
- ONEW $1,790,054,000.00
- Revenue This Year
- ACIU N/A
- ONEW $4.82
- Revenue Next Year
- ACIU $1,022.98
- ONEW $2.96
- P/E Ratio
- ACIU N/A
- ONEW N/A
- Revenue Growth
- ACIU 86.71
- ONEW N/A
- 52 Week Low
- ACIU $1.43
- ONEW $11.58
- 52 Week High
- ACIU $3.98
- ONEW $26.78
- Technical
- Relative Strength Index (RSI)
- ACIU 60.92
- ONEW 42.76
- Support Level
- ACIU $2.12
- ONEW $15.67
- Resistance Level
- ACIU $2.35
- ONEW $16.60
- Average True Range (ATR)
- ACIU 0.14
- ONEW 0.62
- MACD
- ACIU 0.04
- ONEW -0.16
- Stochastic Oscillator
- ACIU 76.79
- ONEW 1.44
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About ONEW OneWater Marine Inc.
OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.